↓ Skip to main content

Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

Overview of attention for article published in Frontiers in Pharmacology, June 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
Published in
Frontiers in Pharmacology, June 2023
DOI 10.3389/fphar.2023.1175606
Pubmed ID
Authors

Marco Mele, Paola Imbrici, Antonietta Mele, Maria Vittoria Togo, Giorgia Dinoi, Michele Correale, Natale Daniele Brunetti, Orazio Nicolotti, Annamaria De Luca, Cosimo Damiano Altomare, Antonella Liantonio, Nicola Amoroso

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 15%
Student > Ph. D. Student 2 15%
Unspecified 1 8%
Researcher 1 8%
Student > Master 1 8%
Other 0 0%
Unknown 6 46%
Readers by discipline Count As %
Medicine and Dentistry 3 23%
Unspecified 1 8%
Computer Science 1 8%
Nursing and Health Professions 1 8%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2023.
All research outputs
#19,368,366
of 23,975,876 outputs
Outputs from Frontiers in Pharmacology
#8,955
of 17,664 outputs
Outputs of similar age
#134,367
of 197,964 outputs
Outputs of similar age from Frontiers in Pharmacology
#103
of 432 outputs
Altmetric has tracked 23,975,876 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,664 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,964 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 432 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.